Sage Journals: Discover world-class research

Abstract

Background

Prolonged hospital stay could lead to increased hospital-acquired infections, and unnecessary utilization of hospital beds, medications, and other resources. However, there is limited evidence regarding the length of hospital stay (LOS) and predictors of prolonged hospital stay in pediatric patients with severe pneumonia. Therefore, this study was conducted to fill the information gap on length of stay and predictors of prolonged hospital stay among pediatric patients with severe pneumonia, in southwest Ethiopia.

Objective

This study aimed to determine the LOS and predictors of prolonged hospital stay among pediatric patients with severe pneumonia, Southwest Ethiopia/2022.

Methods and Materials

A Prospective follow-up study was conducted on pediatric patients with severe pneumonia. Data were entered into Epi-data manager Version 4.4.2.1, for coding, editing, and cleaning, then exported to Stata Version 16 for analysis. Bivariate logistic regression analysis at a significance level of 0.25 and multivariate logistic regression analyses with a significance level of 0.05 were conducted to determine the factors associated with prolonged hospital stay among pediatric patients.

Results

In this study, the median LOS was 5 days and, approximately 38.22% (95% CI [33.66-43.01]) of patients with severe pneumonia had prolonged hospital stays. The presence of underlying comorbidity (adjusted odds ratio [AOR]: 2.64, 95% CI [1.65-4.26]), health insurance status (AOR: 2.22, 95% CI [1.4-3.55]), and incomplete vaccination status (AOR: 4.20, 95% CI [1.04-16.61]) were independent predictors of prolonged hospital stay among pediatric patients with severe pneumonia.

Conclusion

In this study, more than one-third of pediatric patients with severe pneumonia had a length of stay of more than 5 days, and incomplete vaccination status, insurance status, and underlying comorbidities were independent predictors of prolonged hospital stay. Therefore, healthcare providers, parents, and other stakeholders should work to improve the pneumococcal vaccination rate, timely initiation of advanced diagnosis, and patient management of comorbid diseases to reduce hospital stays for pediatric patients with severe pneumonia.

Keywords

associated factors pediatric patients prolonged hospital stay severe pneumonia southwest Ethiopia

Background

The World Health Organization (WHO) defines severe pneumonia as an infectious disease diagnosed in children with a history of cough or reported breathing difficulty and at least one of the following: low oxygen saturation severe respiratory distress, general danger signs, and age-specific increased respiratory rate.^1,2

Pneumonia is associated with high health costs of hospitalization and death worldwide.³ Globally pneumonia in children accounts for approximately 10 to 20 million hospitalizations with an annual incidence of 150 to 156 million cases,⁴ and each year, almost 700 000 children die from pneumonia; every minute 2 children die from pneumonia: out of these, 80% of mortality occurs in low and middle-income countries including, Ethiopia.⁵

There is wide variation in clinical practice in the treatment of severe pneumonia, which leads to different in-patient hospital stays among patients. Caring for a child with pneumonia in the case of prolonged hospitalization may be financially burdensome in resource-poor areas where parents need to pay for treatment at the point of care.^6,7 Medical costs (direct and indirect) of care show a significant difference based on how long a child is hospitalized and depending on the charge for different conditions, and the total medical costs directly related to the costs of hospital admission and length of stay.^8–10 Prolonged hospitalization for severe pneumonia exposes the patients to the development of adverse drug reactions and the chance of another hospital-acquired infection, takes time away from work for parents, and is a burden on time expenditure by clinical staff.^11,12 Aside from case fatality, length of hospitalization is a commonly accepted indicator of pneumonia severity.^7,13

Previous studies have shown that patients who stay longer in hospitals have poor and unfavorable treatment outcomes.^6,14 Treatment outcomes and the length of stay for hospitalized pneumonia patients until recovery are influenced by various factors such as comorbidities, complications, severity, and type of drug prescribed.^15,16 A study conducted in, Gambia revealed that approximately 25.0% of the children with pneumonia had a prolonged hospital stay while malnutrition severe wasting, and hypoxemia at presentation were independent predictors.⁷

In Ethiopia, trials are underway to prevent the onset of pneumonia in children such as pneumococcal conjugate vaccines (PCVs), develop integrated treatment strategies for newborn and childhood illnesses to treat pediatric patients, and reduce morbidity and mortality. The Ethiopian 2015 health sector transformation planned to reduce the mortality rate of children to 31 and 14 per 1000 live births in 2025 and 2035 respectively.¹⁷ Despite these plans, strategies, and initiatives, Ethiopia has a high incidence of pneumonia, a high rate of hospitalization, and a higher risk of mortality, and is categorized among the top five nations with the highest number of pneumonia deaths.¹⁸

A retrospective follow-up study conducted in Benshangulgumuze, Ethiopia revealed that approximately 28.93% of the children with pneumonia had a prolonged hospital stay(>5 days) while having facility referral, nutritional status of wasting, anemia, no identified hemoglobin level and no identified blood film presentation were independent predictors.¹⁹

Although studies have been conducted in different hospitals in Ethiopia on the time to recovery and mortality rate of pneumonia, there is not enough evidence on the length of hospital stay (LOS) and predictors of prolonged hospitalization among pediatric patients with severe pneumonia. Therefore, this study aimed to determine the LOS and predictors of prolonged hospitalization among pediatric patients with severe pneumonia admitted to public hospitals, in Southwest Ethiopia to provide evidence on length of stay and predictors of prolonged hospital stay among pediatric patients with severe pneumonia.

Methods and Materials

Study Design

An institution-based prospective follow-up study was conducted among pediatric patients with severe pneumonia admitted to public hospitals in the southwest region, of Ethiopia.

Study Area and Period

This study was conducted in public Hospitals, in the Southwest region, of Ethiopia, which is a newly established region. There are eight well-known public Hospitals: Out Of the eight hospitals; MizanTepi University Teaching Hospital (MTUTH), G/TsadikShawo General Hospital, Tepi General Hospital, and Wacha Primary Hospital were selected using a lottery method. The MTUTH is located 584 km from Addis Ababa. It served as a referral center. TheTepi General Hospital is located 622 km from Addis Ababa. The G/tsaddikShewa General Hospital is located in the Keffa zone Bongatown, which is 464 km from Addis Ababa, and the Wacha primary hospital is located in Wacha-maji town. All Hospitals provided outpatient care and inpatient services for pediatric problems including severe pneumonia. The study was conducted from June 1 to November 30, 2022, in 4 selected public hospitals.

Study Participants

All pediatric patients (aged 1 month to 15) years with severe pneumonia admitted to public hospitals, in Southwest Ethiopia were the source population. All sampled and selected pediatric patients with severe pneumonia admitted to selected public hospitals, in Southwest Ethiopia during the data collection period were the study population.

Eligibility Criteria

All pediatric patients with severe pneumonia who were in the age categories of 1 month to 15 years were eligible for participation, while pediatric patients with severe pneumonia who were below 1 month and above 15 years, readmitted patients and patients with incomplete observation during follow-up; and unknown dates of admission and discharge were excluded.

Sample Size Determination, Sampling Technique, and Procedure

The sample size was determined by using a single population proportion formula considering the following assumptions; 95% confidence level, margin of error (0.05), and proportion (P) of prolonged hospitalization for pneumonia as 50%, since there is no previous study in Ethiopia the sample was calculated as follows:

n = (Zα/2)² × p (1-p)/(d)²

n = (1.96)²× 0.5 × (1 − 0.5)/(0.05)²= 384: After adding a nonresponse rate of 10% (19.2 ≈ 20), the final sample size was 422.

Sample size distribution to each hospital was conducted using the formula: ni = $\frac{n}{N}$ *Ni for each hospital based on the number of pediatric patients with severe pneumonia admitted in the pediatrics ward, where n = sample size (422), N = total number of children with severe pneumonia (791) and Ni = total pediatrics patients with severe pneumonia at each hospital.

Finally, 67 children from Wacha Primary Hospital, 114 from G/tsaddik Shewa, 118 from Tepi General Hospital, and 123 from MTUTH were obtained from 422 pediatric patients with severe pneumonia. After allocation, the sampling interval (kth) was calculated as the total number of children admitted with severe pneumonia divided by the sample size (791/420 = 1.8∼2). Then, at every interval, participants were selected after the first eligible patients were selected by the lottery method on the planned date of data collection.

All the selected respondent's medical record number was recorded in one single sheet to remove redundancy if the child came for readmission during our data collection period.

Among the 422 sampled patients with severe pneumonia, 6 patients were lost to follow-up, withdrew, and were referred to another hospital. Data from 416 patients with severe pneumonia were included.

Study Variables

Dependent variables: Prolonged hospital stay among severe pneumonia patients.

Independent variables: include the following subheadings.

✓ Sociodemographic characteristics: include: patient sex, age, residency, and maternal education level

✓ Nutritional status of the children: Weight for age, height for age, weight for height, feeding status, and mode of infancy feeding of patients with severe pneumonia

✓ Clinical and therapeutic characteristics: Such as body temperature at admission, antibiotic administration, clinical presentation, danger signs during admission, history of drug regimen, and oxygen saturation at admission.

✓ Comorbidity and complication characteristics: Human immune virus (HIV) infection status, heart failure, congenital heart disease, asthma, down syndrome, DM, hyperactive airway illness, complication during hospital stay, and history of acute respiratory infection

Operational Definitions

Prolonged Hospital Stay

A prolonged LOS was considered an outcome variable in the study, defined as the time from hospital admission to hospital discharge. It was dichotomized as ≤5 and >5 days based on the median time (length) of hospital stay. Patients who stayed in the hospital for more than five days were categorized as having “prolonged” hospitalization.^7,19

Severe Pneumonia

Patients were diagnosed with severe pneumonia by pediatricians working in the pediatric emergency rooms of each hospital using standardized baseline assessment methods such as medical history, clinical examination, laboratory tests, and radiography.

Vaccination Status

Fully vaccinated is defined as being vaccinated according to the Ethiopian EPI guidelines, and partially immunized (vaccinated) is defined as not being vaccinated according to the Ethiopian EPI guidelines in the absence of certain vaccinations.²⁰

Comorbidity

Any disease condition (acute or chronic) present at admission in addition to severe pneumonia which includes childhood asthma, HIV, anemia, meningitis, bronchitis, and urinary tract infection.²¹

Time Scale

The LOS was measured in days.

Starting Time Origin

The first day of admission of children at the pediatric ward or if the child acquired severe pneumonia in the hospital, the diagnosis date of severe pneumonia was considered as the first day of admission.

End of Follow-Up/Ending Time

Specific time of discharge from the hospital.

Follow-Up Time

This is the duration of time from admission to the hospital from severe pneumonia to discharge from the hospital.

Data Collection Tools and Procedures

The data collection tool was adapted and modified after reviewing other related literature,^3,7,22,23 and prepared in English and translated into a local language, then retranslated back into English. Data were collected through face-to-face interviews with mothers and day-to-day patient follow-ups using medical charts and vital sign sheets. Two BSc nurses who had previous data collection experience were collecting the data, and 1 MSc nurse supervisor was assigned in each hospital to supervise the data collection process.

Data Processing and Analysis

Data were entered into Epi-data Manager Version 4.4.2.1, for coding, editing, and cleaning, then exported to Stata Version 16 for analysis. Predictors of a prolonged hospital stay were identified using a logistic regression model. The logistic regression model of the fitness test was assessed using the Hosmer and the Lemeshow test, and the model was fitted. Variables with a P-value < .25 in the bivariate logistic regression analysis were transferred to the multivariable logistic regression analysis. Then, variables with a P-value < .05 at a 95% confidence level in multivariate analysis were considered independent predictors of a prolonged hospital stay.

Data Quality Assurance

A pretest was conducted on 5% of the sample size before the actual data collection period then editions, wordings, and sequencing of questions were made on the data collection tool. One day of training was provided to the data collectors and supervisors on the techniques, objectives of data collection, and ethical research issues. Supervisors regularly checked the completed questionnaires and provided immediate feedback to data collectors.

Patient and Public Involvement

There was no patient/public involvement in the development of the research question or the design, conduct, reporting, implementation, or dissemination plans or evaluation of the study.

Results

From the total sample of 422 children diagnosed with severe pneumonia, only 416 completed the follow-up during the study period and gave a response rate of 98.58%.

Sociodemographic Characteristics of Pediatric Patients and Their Mothers

In this study, more than half (55.3%) of pediatric patients with severe pneumonia were male, and 246 (59.1%) pediatric patients were found in the 1 to 5 years age categories. most of the participants (57.5%) of pediatric patients were from urban residences (Table 1).

Table 1.

Sociodemographic Characteristics of Pediatric Patients With Severe Pneumonia Admitted In Public Hospitals, Southwest, Ethiopia, 2022/2023 (N = 416).

Characteristics	Categories	Frequency	Percentage (%)
Sex	Male	230	55.3
Sex	Female	186	44.7
Age of the patients	1month-1 year	129	31.0
	1-5 year	246	59.1
	5-14 year	41	9.9
Birth weight	<2500 g	75	18.0
Birth weight	≥2500 g	341	82.0
Gestational age	< 37 weeks	116	27.9
Gestational age	≥37 weeks	300	72.1
Residency	Urban	239	57.5
Residency	Rural	177	42.5
Mother educational level	unable to read and write	137	32.9
	Able to read and write	121	29.1
	Primary school completed	70	16.8
	Secondary school	34	8.2
	graduated diploma/degree	54	13.0

Nutritional Status of the Pediatric Patients

In this study, the majority 77.6% of pediatric patients with severe pneumonia had a history of exclusive breast-feeding. More than 90% of pediatric patients with severe pneumonia had normal nutritional status, whereas underweight, stunting, and wasting were in 38 (9.1%), 30 (7.2%), 34 (8.2%) pediatric patients with severe pneumonia respectively (Table 2).

Table 2.

Nutritional Status of Pediatric Patients With Severe Pneumonia Admitted in Public Hospitals, Southwest, Ethiopia, 2022/2023 (N = 416).

Characteristics		Category	Frequency	Percentage (%)
Nutritional status	WFA	Normal weight	378	90.9
	WFA	Underweight	38	9.1
	HFA	Normal	386	92.8
	HFA	Stunted	30	7.2
	WFH	Normal	382	91.8
	WFH	Wasting	34	8.2
Mode of infancy feeding		Breast milk	334	80.3
		Formula feeding	20	4.8
		Cow milk	62	14.9
Exclusive breastfeeding		Yes	323	77.6
Exclusive breastfeeding		No	93	22.4
Having loss of apatite		No	413	99.3
Having loss of apatite		Yes	3	0.7

Clinical Characteristics of Pediatric Patients With Severe Pneumonia

In this study, one 191 (45.9%) pediatric patients with severe pneumonia had hypoxia during hospital admission, and 391 (94%) patients had danger signs during admission. Two hundred sixty-two (63.0%), 141(33.9%), and 71(17.1%) patients had respiratory distress signs, high-grade fever, and altered consciousness respectively (Table 3).

Table 3.

Clinical Characteristics of Pediatric Patients With Severe Pneumonia Admitted In Public Hospitals, Southwest, Ethiopia, 2022/2023 (N = 416).

Clinical characteristics	Categories	Frequency	Percentages (%)
Hypoxia during admission(<90% oxygen saturation)	No	225	54.1
Hypoxia during admission(<90% oxygen saturation)	Yes	191	45.9
Having a danger sign during admission	No	25	6.0
Having a danger sign during admission	Yes	391	94.0
Respiratory distress	No	154	37.0
Respiratory distress	Yes	262	63.0
High grade fever (>38.5°C)	No	275	66.1
High grade fever (>38.5°C)	Yes	141	33.9
Vomiting	No	395	95.0
Vomiting	Yes	21	5.0
Convulsion	No	385	92.5
Convulsion	Yes	31	7.5
Altered consciousness	No	345	82.9
Altered consciousness	Yes	71	17.1
Inability to breastfeed/drink	No	333	80.0
Inability to breastfeed/drink	Yes	83	20.0
Abnormal body movement	No	375	90.1
Abnormal body movement	Yes	41	9.9

Therapeutic/Interventional Characteristics of Patients With Severe Pneumonia

In this study, the majority (67.1%) of the pediatric patients with severe pneumonia had a history of taking antibiotics before admission to the hospital, and most of them were taking Ceftriaxone. Antibiotics had changed after admission in the hospital for 206 (949.5%) of pediatric patients. More than half of the children and their parents (54.6%) were not insured (did not have community health insurance), and only 150 (36.1%) pediatric patients had completed their recommended vaccination appropriate to their age (Table 4).

Table 4.

Therapeutic Characteristics of Pediatric Patients With Severe Pneumonia Admitted in Public Hospitals, Southwest, Ethiopia, 2022/2023 (N = 416).

Therapeutic characteristics	Categories	Frequency	Percentages (%)
Antibiotics given before hospital admission	Yes	279	67.1
Antibiotics given before hospital admission	No	137	32.9
Antibiotic first given	Crystalline penicillin	92	22.1
	Ceftriaxone	251	60.3
	Ampicillin and gentamicin	73	17.5
Antibiotic change after admission	No	210	50.5
Antibiotic change after admission	Yes	206	49.5
Need respiratory support during hospital admission	Yes	169	40.6
Need respiratory support during hospital admission	No	247	59.4
Required oxygen support during admission	Yes	174	41.8
Required oxygen support during admission	No	242	58.2
Received mechanical ventilation	Yes	63	15.1
Received mechanical ventilation	No	353	84.9
Chest X-ray findings during admission	Normal	377	90.6
Chest X-ray findings during admission	Abnormal	39	9.4
Timing of health care seeking	Within 5 days	400	96.2
Timing of health care seeking	After 5 days	16	3.8
Insurance status	Insured	189	45.4
Insurance status	Not insured	227	54.6
Vaccination status	Vaccinated up-to-date	128	30.8
	Partially vaccinated	120	28.8
	Fully vaccinated	150	36.1
	None vaccinated	18	4.3

Pediatric Comorbidity Among Pediatric Patients With Severe Pneumonia

In this study, approximately 15.1% of patients with severe pneumonia had other co-morbidities in addition to having severe pneumonia, and HIV infection, asthma, and malaria account for 3.4%, 4.3%, and 2.2% of comorbidities respectively (Table 5).

Table 5.

Pediatrics Comorbidity Characteristics of Pediatric Patients With Severe Pneumonia Admitted In Public Hospitals, Southwest, Ethiopia, 2022/2023 (N = 416).

Characteristics	Category	Frequency	Percentage (%)
Comorbidity	Yes	63	15.1
Comorbidity	No	353	84.9
HIV-infection	No	402	96.6
HIV-infection	Yes	14	3.4
congenital heart diseases	No	410	98.6
congenital heart diseases	Yes	6	1.4
Asthma	No	398	95.7
Asthma	Yes	18	4.3
Chronic pulmonary disease	No	410	98.6
Chronic pulmonary disease	Yes	6	1.4
Malaria	No	407	97.8
Malaria	Yes	9	2.2
Anemia	No	412	99.0
Anemia	Yes	4	1.0
Others	Yes	6	1.4

Others: include, DM, Down's syndrome and bronchitis.

Lengths of Hospital Stay Among Pediatric Patients With Severe Pneumonia

In this study, the median time of hospitalization was 5 days with an interquartile range (IQR) of 4 to 7 days. The majority of patients with severe pneumonia, 61.78% (95% CI [56.99-66.34]) had stayed in the hospital for less than five days, and approximately 38.22% (95% CI [33.66-43.01]) severe pneumonia patients were hospitalized for more than five days of duration (Figure 1).

Figure 1.

Length of hospitalization among pediatric patients with severe pneumonia admitted in public hospitals, in southwest Ethiopia (N = 416).

Predictors of Prolonged Hospitalization

During the bivariate logistic regression analysis, the independent variables with a significance level of < .25 were transferred to multivariate logistic regression analysis, and variables with a significance level of 0.05 during multivariate logistic analysis were considered as predictors of prolonged hospital stay.

In this study, independent variables such as residency, nutritional status (WFA, WFH, and HFA), signs of respiratory distress, convulsion, comorbidity, history of previous respiratory infection, vaccination status, and insurance were significant in the bivariate logistic regression analysis. Finally, vaccination status (incomplete vaccination), insurance status (not insured), and having comorbidity diseases, were independent predictors of prolonged hospital stay in pediatric patients with severe pneumonia. Pediatric patients with severe pneumonia and comorbidity (additional disease) had 2.64 times higher odds of prolonged hospital stay than those who were only diagnosed with severe pneumonia (adjusted odds ratio [AOR]: 2.64, 95% CI [1.65-4.26]).

Additionally, in this study severe pneumonia pediatric patients who were insured with community health insurance had 2.22 times longer odds of hospitalization than those who were not insured with community health insurance (AOR: 2.22, 95% CI [1.4-3.55]). Severe pneumonia pediatric patients who did not complete the recommended vaccination had 4.2 times higher odds of hospitalization than pediatric patients with severe pneumonia who had completed their recommended vaccination (AOR: 4.20 (95% CI [1.04-16.61]) (Table 6).

Table 6.

Predictors of Prolonged Hospitalization Among Pediatric Patients With Severe Pneumonia Admitted in Public Hospitals, Southwest Ethiopia (N = 416).

Characteristics	Category	Duration of hospital stay		COR [95% CI]	AOR [95% CI]	P-value
Characteristics	Category	≤5	>5 days	COR [95% CI]	AOR [95% CI]	P-value
Residency	Urban	154 (64.44)	85 (35.56)	1	1
Residency	Rural	103 (58.19)	74 (41.81)	1.32 [0.87-1.94]	0.95 [0.60-1.51]	.839
weight for age	Normal	240 (63.49)	138 (36.51)	1	1
weight for age	Underweight	17 (44.74)	21 (55.26)	2.15 [1.10-4.21]	0.55 [0.13-2.35]	.417
Height for age	Normal	248 (64.25)	38 (35.75)	1	1
Height for age	Stunted	9 (30.00)	21 (70.00)	4.20 [1.87-9.41]	2.18 [0.52-9.12]	.284
weigh for height	Normal	246 (64.40)	138 (35.60)	1	1
weigh for height	Wasting	11 (32.35)	23 (67.65)	3.78 [1.79-7.99]	2.09 [0.36-12.24]	.414
Respiratory distress sign	No	111 (72.08)	43 (27.92)	1	1
Respiratory distress sign	Yes	146 (55.73)	116 (44.27)	2.05 [1.34 3.15]	1.68 [1.03-2.71]	.36
Convulsion	No	242 (62.86)	143 (37.14)	1	1
Convulsion	Yes	15 (48.39)	16 (51.61)	1.81 [0.87-3.76]	1.05 [0.44-2.54]	.909
Comorbidity	No	203 (70.24)	86 (29.76)	1	1
Comorbidity	Yes	54 (42.52)	73 (57.48)	3.19 [2.07-4.20]	2.64 [1.65-4.26]	.001
Previous Respiratory infection	Yes	139 (54.30)	117 (45.70)	0.42 [0.28-0.65]	0.48 [0.29-0.77]	.43
Previous Respiratory infection	No	118 (73.75)	42 (26.25)	1	1
Insurance	Insured	227 (67.20)	62 (32.80)	1	1
Insurance	Non insured	130 (57.27)	97 (42.73)	1.53 [1.03-2.28]	2.22 [1.4-3.55]	.001
Vaccination status	vaccinated up-to-date	96 (75.00)	32 (25.00)	3.81 [0.44-32.87]	2.38 [0.21-28.50]	.493
	Partially vaccinated	54 (45.00)	66 (55.00)	5.76 [1.73-19.19]	4.20 [1.04-16.61]	.044
	Nonvaccinated	8 (44.44)	10 (55.56)	2.43 [0.90-6.53]	1.66 [0.52-5.23]	.389
	Fully vaccinated	99 (66.00)	51 (34.0)	1	1

Note: *, significant at P < .05:1.00, considered as reference categories; COR-crude odds ratio and AOR-adjusted odds ratios.

Discussion

This prospective follow-up study was conducted to determine the LOS and to identify the predictors of prolonged hospitalization among pediatric patients with severe pneumonia.

In this study, the median time of hospitalization was 5 days with an IQR of 4 to 7, which was similar to the results from previous studies conducted in Benshangulgumze, Ethiopia,¹⁹ and comprehensive health at Masse Major Health center, Gambia,⁷ Where the median hospital stay was 5 and 4.5 days respectively.

However, the LOS among pediatric patients with severe pneumonia in this study was lower than that in previous studies conducted in Japanese health centers,²² and hospitals in Switzerland,²⁴ where the LOS was 9.8 days and 11 (IQR, 8-17) days respectively. A possible reason for these differences might be variations in the level of quality of care, sample size difference, sociodemographic, and other parameter variations among studies.

The variation in the study conducted in Japan might be because of the varying methods of data collection using different sources of data (primary/secondary). This study used primary data sources during follow-up and had data that were more accurate and reliable regarding the specific/actual time of admission and discharge of patients. However, the Japanese study used secondary data/care review, which makes it difficult to obtain actual data on their charts; therefore, the actual LOS of patients might be overreported.

The study showed that there was a significantly high level of prolonged hospitalization 38.22% (95% CI [33.66-43.01]) in pediatric patients with severe pneumonia. This was higher than the studies conducted at Benshangulgumze, Ethiopia,¹⁹ and at Basse Major Health Center, Gambia,⁷ where 28.93% and 25.0% of the patients had a prolonged hospital stay respectively. however, this was lower than the study conducted on patients community community-acquired pneumonia in a teaching hospital in Valencia (Spain)²⁵ where prolonged hospitalization was recorded in the other 68% of patients.

The possible reason for this difference with the study conducted at Benshangulgumze, Ethiopia¹⁹might be due to variations in the quality of care provided during hospitalization and the source of data; this study was conducted prospectively using primary data sources, whereas the study conducted at Benshangulgumze, Ethiopia was conducted retrospectively using secondary data sources.

The variation in the study conducted at Gambia, and Valencia (Spain)²⁵ also might be because of varying methods of clinical practice and contextual factors such as laboratory equipment and sociodemographic differences of the population served between countries.

In this study, the prolonged hospitalization of patients with severe pneumonia was multifactorial, and vaccination status (incomplete vaccination), insurance status (not insured), and comorbidities were independent predictors of prolonged hospital stay.

Patients with severe pneumonia and comorbidities (having additional diseases) had 2.64 times higher odds of prolonged hospital stay than those who were only diagnosed with severe pneumonia, which is supported by other studies.^3,26–28 This might be because the occurrence of one or more underlying comorbid diseases is associated not only with a greater risk of developing pneumonia but also worsens pneumonia prognosis, increases hospital stays, and may lead to patient death. However, this is open to future research to understand the impact of co-morbidities on the prognosis of severe pneumonia using clinical and diagnostic variables, and severity index scores in patients with severe pneumonia.

Patients with community health insurance had 2.22 times longer odds of hospitalization than those without community health insurance. This was supported by previous studies in the United States, California,²⁹ Washington DC,³⁰ and China,³¹whichis an expected result because patients who had insurance and the ability to pay out-of-pocket inpatient care had good health-seeking behavior and waited until the recommended discharge time, which affects the LOS. However, this result was in contrast to a study conducted in Uganda³² which revealed that insured patients had a significantly shorter length of stay. However, this is open to further rigorous study to identify the effect of insurance on pediatric hospital stay and to differentiate the length of stay among the insured and not insured to solidify the evidence guiding future policy development in Ethiopia.

Pediatric patients with severe pneumonia who did not complete the recommended vaccination had 4.2 times higher odds of hospitalization than those who had completed their recommended vaccination for age, which is similar to the results of a study conducted in the Philippines.³³This might be because there is an increased severity of pneumonia and other comorbidities in pediatric patients who have been partially or not vaccinated completely, and the effect of PCV on the reduction in the pneumonia hospitalization burden.³⁴However, data to determine the contribution of PCV to the prognosis of pneumonia are missing. Therefore, the relationship between PCV and length of hospitalization for severe pneumonia requires further in-depth research. The study was conducted using prospective follow-up and primary data from multicenter public hospitals, which increased data accuracy and reliability. However, this study had some limitations. This study used a relatively small sample size; therefore, it is difficult to generalize the results to all pediatric patients with severe pneumonia, as this study was limited to patients admitted to public hospitals and it cannot be generalized to pediatric patients with severe pneumonia admitted to private health institutions.

Conclusion

This study indicates that approximately more than one-third of a pediatric patient with severe pneumonia had prolonged hospital stays of more than 5 days, and incomplete vaccination status, insurance status, having underlying comorbidities were independent predictors of prolonged hospital stay to pediatric patients with severe pneumonia. Therefore, advanced and special care should be given to pediatric patients with severe pneumonia with a special focus on patients with underlying comorbidity, and who did not complete the recommended vaccination for age during their hospital stay. This study may be helpful to healthcare providers and policymakers in developing strategies for the advanced management of patients with severe pneumonia at a higher risk of prolonged length of stay.

Footnotes

Acknowledgments

Our thanks also go to Mizan-Tepi University Teaching Hospital (MTUTH), Tepi General Hospital, G/tsaddik Shewa General Hospital, and Wacha primary hospital staff of the pediatrics ward, our appreciation extended to the study participants, data collectors, and supervisors.

Author Contributions

All authors made a significant contribution to the work reported; whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation; or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethics Approval and Consent to Participate

Before data collection, ethical clearance was obtained from the Mizan-Tepi University ethical review board with reference number HSC/00103/2014, and a formal letter of cooperation was written for each public hospital. After receiving an explanation of the objectives of the study, confidentiality, and benefits of the study, all parents gave informed consent for the participation of the pediatric patients in the study. Additionally, the names of participants were not used in the study. Participants (mothers) were informed that they had the right to participate in the study as well as to interrupt/withdraw/at any time during follow-up.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

ORCID iDs

Belete Fenta Kebede

Yalemtsehay Dagnaw Genie

Tsegaw Biyazin Tesfa

Aynalem Yetwale Hiwot

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Author Biographies

Belete Fenta Kebede is a lecturer at Jimma University, School of Midwifery; writes and publishes on both medical sciences and business management.

Yalemtsehay Dagnaw Genie is a lecturer at Debire Markos University, Department of Pediatrics and Child Health Nursing; writes and publishes on all fields of medical sciences.

Tsegaw Biyazin Tesfa is a lecturer at Jimma University, School of Midwifery; writes and publishes on medical sciences especially on midwifery and reproductive health.

Aynalem Yetwale Hiwot is a lecturer at Woldiya University, Woldiya, Ethiopia, lecturer and clinical midwifery expert; writes and publishes on medical sciences especially on midwifery and reproductive health.

Kassa Kindie Mulu is a lecturer at Department of Nursing, Mizan-Tepi University, Mizan-Teferi, Ethiopia; writes and publishes on all fields of medical sciences.

Emebet Adugnaw is a lecturer at Department of Public Health, Mizan-Tepi University, Mizan-Teferi, Ethiopia; public health expert and writes and publishes on medical sciences.

Esmelalem Mihretu is a lecturer at Debire Markos University, Department of Pediatrics and Child Health Nursing; writes and publishes on pediatrics and child health.

Enatfenta Sewmehone Endalew is a lecturer at Jimma University, School of Nursing; writes and publishes on medical sciences especially on nursing and maternity health.

References

Scher

Dokianakis

Steppe

Banks

. Computer classification of state in healthy preterm neonates pediatrics and sleep computer classification of state in healthy preterm neonates. Am Sleep Disord Assoc Sleep Res Soc Pediatr. 2017;20(2):1–11.

Mackenzie

. The definition and classification of pneumonia. Biomed Cent [Internet]. 2016;8(14):1–5. https://doi.org/10.1186/s41479-016-0012-z

Sitompul

Indriani

Maemun

, et al. Length of stay of pneumonia patients associated with comorbid and complications factors in referral national infectious diseases hospital. Tanzan J Health Res. 2023;24(1):1–5.

Hassen

Toma

Tesfay

, et al. Radiologic diagnosis and hospitalization among children with severe community-acquired pneumonia: a prospective cohort study. BioMed Res Int. 2019;62(02):1–8.

Fact sheet: World Pneumonia Day. Forum Int Respir Soscietis. 2019;(November):2019.

Basnet

Sharma

Mathisen

Shrestha

. Predictors of duration and treatment failure of severe pneumonia in hospitalized young Nepalese children. Plose One. 2015;10(3):1–11.

Kuti

Chb

Adegoke

, et al. Predictors of prolonged hospitalization in childhood pneumonia in a rural health center. SAJCH. 2014;8(1):1–5.

Porfirio

Junior

Lúcia

Sgambatti

Toscano

. Hospitalization costs of severe bacterial pneumonia in children : a comparative analysis considering different costing methods. Heal Econ Manag. 2017;15(55 99):212–219.

Sulley

Ndanga

. International journal of pediatrics and pediatric pneumonia : an analysis of cost & outcome influencers in the United States. Int J Pediatr Adolesc Med. 2019;6(3):79–86.

10.

Zhang

Sammon

King

Andrade

Toscano

Araujo

. Cost of management of severe pneumonia in young children : systematic analysis. J Glob Health. 2016;6(1):104–108.

11.

Bozzani

Arnold

Colbourn

, et al. Measurement and valuation of health providers’ time for the management of childhood pneumonia in rural Malawi: an empirical study. BMC Health Serv Res. 2016;16(1):314. https://doi.org/10.1186/s12913-016-1573-5

12.

Ayieko

Akumu

Griffiths

, et al. The economic burden of inpatient pediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria, and meningitis. Cost Effect Resource Alloc. 2009;7(1):3. https://doi.org/10.1186/1478-7547-7-3

13.

Tiewsoh

Lodha

Pandey

Broor

Kalaivani

Kabra

. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr. 2009;7(3):1–13.

14.

Tsegaw

Yimam

Nureye

Woldeselassie

Hambisa

. Predictors of treatment outcomes among pediatric patients hospitalized with pneumonia in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Adv Pharmacol Pharm Sci.2021;2021:1–7. vol. 2021, pp. 1-7. https://doi.org/10.1155/2021/6690622

15.

Yehuala

Teka

. Survival analysis of premature infants admitted to neonatal intensive care unit (NICU) in northwest Ethiopia using semi-parametric frailty model. J Biom Biostat. 2015;6(1):1–12.

16.

Shebl

Said

El-korashi

Ibraheem

. The outcome of hospital-acquired pneumonia in patients admitted for long-term care according to the antibiotic duration. Egypt J Chest Dis Tuberculosis. 2019;68(2):378–382.

17.

Federal Ministry of Health, Ethiopia. Health Sector Transformation Plan 1 Version 1 Annual Performance Report EFY (2015/16); 2015.

18.

Mcallister

Liu

Shi

, et al. Articles global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015 : a systematic analysis. Lancet Glob Heal. 2019;7(1):e47–e57.

19.

Dinku

Amare

Mulatu

Abate

. Predictors of prolonged hospitalization among children. Front Pediatr [Internet]. 2023;11(11):1–9. https://doi.org/10.3389/fped.2023.1189155

20.

Ministry Of Health-Ethiopia. Expanded program on immunization (EPI). Accessed 26 June 2023. https://www.moh.gov.et/site/initiatives-4-col/Expanded_Program_on_Immunization.

21.

Tesfa

Kassie

. Time to recovery and predictors of severe community-acquired pneumonia among pediatric patients in Debre Markos referral hospital, North West Ethiopia : a retrospective follow-up study. PLOS ONE. 2020;15(2):1–15. https://doi.org/10.1371/journal.pone.0239655

22.

Uematsu

Yamashita

Kunisawa

, et al. A prediction model for prolonged length of stay in patients with community-acquired pneumonia based on Japanese administrative data. Respir Investig. 2021;59:194–203. https://doi.org/10.1016/j.resinv.2020.08.005

23.

Siegel

. How long a stay in the hospital is needed for patients with community-acquired pneumonia? Am J Med. 2000;109(5):434–436. https://doi.org/10.1016/S0002-9343(00)00525-8

24.

Suter-widmer

Christ-crain

Zimmerli

Albrich

Mueller

. Predictors for the length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study. BMC Pulm Med. 2012;12(21):1–9. https://doi.org/10.1186/1471-2466-12-21

25.

Ferrando

Valle

. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J. 2001;18(1):151–156.

26.

Hespanhol

Bárbara

. Pneumonia mortality, comorbidities matter?. Pulmonology. 2020 May-Jun;26(3):123–129. https://doi.org/10.1016/j.pulmoe.2019.10.003

27.

Piazza

Moreira

Lana

Reis

Cherchiglia

. Comorbidities and in-hospital death of viral pneumonia adults admitted to SUS. Rev Saude Publica. 2021;12(55):1–11.

28.

Ghosh

. AJHM Volume 4 Issue 1 (Jan-March 2020) ORIGINAL ARTICLE. 2020;4(1):1-10.

29.

With

Care

Iii

AGM

Everett

Knoll

Carolina

. Impact of insurance and hospital ownership on hospital length of stay among conditions. Ann Fam Med. 2011;9(6):489–495.

30.

Englum

Hui

Zogg

, et al. Association between insurance status and hospital length of stay following trauma. Am Surg. 2016;82(3):281–288.

31.

Chu

Jiang

Zhang

Luan

. Effects of medical insurance system on the hospitalization cost of acute myocardial infarction patients. Cost Eff Resour Alloc. 2022;20(1):1–8. https://doi.org/10.1186/s12962-022-00343-6

32.

Haven

Dobson

Yusuf

, et al. Community-based health insurance increased health care utilization and reduced mortality in children under-5, around Bwindi Community Hospital, Uganda between 2015 and 2017. Front Public Health. 2018;6(October):1–10.

33.

Nadlang

MKM

Jopson

MEI

. Factors affecting prolonged hospitalization in children 6 months to 5 years with severe community-acquired pneumonia. Herdin. 2023;17(1):35–44.

34.

Simonsen

Taylor

Young-xu

Haber

May

Klugman

. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio. 2011;2(1):1–10.

Predictors of Prolonged Hospital Stay Among Pediatric Patients With Severe Pneumonia,Southwest Ethiopia: Prospective Follow-Up Study

Abstract

Background

Objective

Methods and Materials

Results

Conclusion

Keywords

Background

Methods and Materials

Study Design

Study Area and Period

Study Participants

Eligibility Criteria

Sample Size Determination, Sampling Technique, and Procedure

Study Variables

Operational Definitions

Prolonged Hospital Stay

Severe Pneumonia

Vaccination Status

Comorbidity

Time Scale

Starting Time Origin

End of Follow-Up/Ending Time

Follow-Up Time

Data Collection Tools and Procedures

Data Processing and Analysis

Data Quality Assurance

Patient and Public Involvement

Results

Sociodemographic Characteristics of Pediatric Patients and Their Mothers

Nutritional Status of the Pediatric Patients

Clinical Characteristics of Pediatric Patients With Severe Pneumonia

Therapeutic/Interventional Characteristics of Patients With Severe Pneumonia

Pediatric Comorbidity Among Pediatric Patients With Severe Pneumonia

Lengths of Hospital Stay Among Pediatric Patients With Severe Pneumonia

Predictors of Prolonged Hospitalization

Discussion

Conclusion

Footnotes

Acknowledgments

Author Contributions

Declaration of Conflicting Interests

Ethics Approval and Consent to Participate

Funding

ORCID iDs

Data Availability Statement

Author Biographies

References